Nektar Therapeutics (0UNL)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 165.44M | 307.71M | 1.19B | 114.62M | 152.92M | 101.91M | 92.06M | 90.12M |
| Operating Income | -112.86M | -43.66M | 687.93M | -440.04M | -379.92M | -446.1M | -313.73M | -263.68M |
| Pre Tax Income | -152.65M | -96.08M | 682.73M | -440.05M | -443.95M | -523.28M | -364.98M | -276.26M |
| Net Income | -153.52M | -96.69M | 681.31M | -440.67M | -444.44M | -523.84M | -368.2M | -276.06M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.002 | -0.606 | 3.926 | -2.497 | -2.468 | -2.824 | -1.953 | -1.447 |
| EBIT | -132.57M | -62.53M | 687.93M | -440.04M | -379.92M | -470.51M | -310.41M | -264.83M |
| EBITDA | -97.5M | -28.92M | 696.73M | -429.04M | -367.42M | -433.1M | -301.53M | -179.37M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
